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Background: Results of ocular biometric measurements in retinal vein occlusion (RVO) eyes are still inconclusive
and controversial. The aim of this study was to evaluate the association between ocular axial length (AL), vitreous
chamber depth (VCD) and both central (CRVO) and branch retinal vein occlusions (BRVO) using optical low
coherence reflectometry (OLCR).
Methods: Both eyes of 37 patients with unilateral CRVO (mean age: 66 ± 14 years, male:female - 21:16) and 46 patients
with unilateral BRVO (mean age: 63 ± 12 years, male:female - 24:22) were enrolled in this study. The control group
consisted of randomly selected single eyes of 67 age and gender matched volunteers without the presence or
history of RVO (mean age: 64 ± 14 years, male:female - 34:33). Optical biometry was performed by OLCR biometer
(LenStar LS 900). Average keratometry readings, central corneal thickness (CCT), anterior chamber depth (ACD),
lens thickness (LT), AL and VCD of eyes with RVO were compared with those of fellow eyes using paired t-tests
and with those of control eyes using independent t-tests.
Results: Mean CCT, ACD and LT, average keratometry readings of affected RVO eyes, unaffected fellow eyes and
control eyes was not statistically different in either groups. In eyes with CRVO mean AL and VCD of affected eyes were
significantly shorter than those of control eyes (p < 0.001, p < 0.05), mean difference in AL and VCD between the
affected and control eyes was 0.56 ± 0.15 mm and 0.45 ± 0.19 mm, respectively. In eyes with BRVO, mean AL of the
affected eyes was significantly shorter with a mean difference of 0.57 ± 0.15 mm (p < 0.001) and the VCD was
significantly shorter with a mean difference of 0.61 ± 0.15 mm (p < 0.001) comparing with the control eyes.
Conclusion: Shorter AL and VCD might be a potential anatomical predisposing factor for development either of
CRVO or BRVO.
Keywords: Retinal vein occlusion, Central retinal vein occlusion, Branch retinal vein occlusion, Axial length,
Vitreous chamber depth, Optical low coherence reflectometryBackground
Retinal vein occlusion (RVO) is the most common form of
retinal vascular disease following diabetic retinopathy, and
may result in permanent vision loss [1]. The Beaver Dam
Eye Study [2] reported a 5-year cumulative incidence of
central retinal vein occlusion (CRVO) of 0.1-0.2%. For a
branch retinal vein occlusion (BRVO) this was approxi-
mately three times more at 0.6%. Many systemic and local
factors can predispose to the development of RVO,* Correspondence: szigandi@gmail.com
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unless otherwise stated.including hypertension, diabetes mellitus, hyperviscosity,
hyperlipidemia and primary open angle glaucoma [1,3-6].
Results of ocular biometric measurements in RVO
eyes are still inconclusive and controversial [7-21]. Some
authors found association between shorter axial length
(AL) or hyperopia and RVO [7-10,14,15,17,18]. In previ-
ous studies, A-scan ultrasonography and partial coher-
ence laser interferometry were performed to measure
AL in eyes with RVO (Table 1) [9-21]. Since A-scan
ultrasonography (US) measures AL from the anterior
cornea to the internal limiting membrane, significantly
shorter AL in RVO eyes compared to control eyesThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Summary of previous studies using AL measurements in patients with CRVO, BRVO or hemispheric retinal vein
occlusion (HRVO) based on A scan ultrasonography (†) or partial coherence laser interferometry (††) measurements [9-21]
Studies (first author, year of publication,
AL measuring method)
Type of RVO Number of patients
with RVO/control eyes
Difference in AL between
affected RVO and unaffected
fellow eyes (mm)
Difference in AL between
affected RVO and control
eyes (mm)
Ariturk (1996) [9]† BRVO 41/66 0.10 0.33*
Timmerman (1997) [10]† BRVO 24/24 0.04 0.6*
Simons (1997) [11]† BRVO 36/36 - 0.07
Bandello (1998) [12]† BRVO 88/50 - 1.03
Kir (1998) [13]† BRVO 50/45 0.02 0.03
Cekic (1999) [14]† BRVO 27/17 0.13 0.37
Tsai (2003) [15]† BRVO 77/67 0.19* 0.85*
Goldstein (2004) [16]† BRVO 24 0.21* -
Mehdizadeh (2005) [17]† BRVO 18/18 0.25* 1.25**
Brown (1990) [18]† CRVO 24/44 0.03 0.67*
Ariturk (1996) [9]† CRVO 17/66 0.36* 0.97**
Kir (1998) [13]† CRVO 39/45 0.07 0.10
Kir (1998) [13]† HRVO 13/45 0.15 0.19
Bandello (1998) [12]† CRVO 58/50 - 0.27
Cekic (1999) [14]† CRVO 19/25 0.62* 0.95*
Tsai (2003) [15]† CRVO 40/67 0.26 0.76*
Mehdizadeh (2005) [17]† CRVO 18/18 0.52* 1.06*
Mirshahi (2005) [19]† CRVO 30/29 0.02 0.23
Moghimi (2007) [20]†† CRVO 29 0.07 -
Gupta (2010) [21]† RVO 25/25 0.83* -
Asterisk indicates a difference that is considered statistically significant (*p < 0.05, **p < 0.001). ( − = not studied).
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complications from RVO (such as macular edema) [20].
Optical low coherence reflectometry (OLCR) provides
high-resolution non-contact measurements of ocular bi-
ometry using superluminescent diode light source that
measures the ocular AL as a distance from anterior cor-
neal surface to the retinal pigment epithelium, meaning
that measurements of AL are unaffected by the presence
of macular edema. In addition to AL, keratometric read-
ings and anterior chamber depth (ACD), the OLCR
biometer is capable of determining the central corneal
thickness (CCT) and lens thickness (LT) as well [22].
Using these data vitreous chamber depth (VCD) can be
calculated.
The purpose of this study was to evaluate the associ-
ation between AL, VCD and RVO using ruling out
measurement altering effects of macular edema.
Methods
This prospective controlled study was performed at the
Department of Ophthalmology, Semmelweis University,
Budapest, Hungary. All participants were treated in ac-
cordance with the tenets of the Declaration of Helsinki.
Institutional Review Board approval was obtained for allstudy protocols (Semmelweis University Regional and In-
stitutional Committee of Sciences and Research Ethics).
Written informed consent was obtained from all partici-
pants in this study.
Thirty seven patients with unilateral CRVO (mean age:
66 ± 14 years, range: 36–92 years, male:female - 21:16)
and 46 patients with unilateral BRVO (mean age: 63 ±
12 years, range: 40–86 years, male:female - 24:22) were
enrolled consecutively as they were referred to the out-
patient clinic of the department for examination during
the last 2 years.
The control group consisted of 67 eyes of 67 randomly
selected age and gender matched volunteers (mean age:
64 ± 14 years, range: 38–90 years, male:female - 34:33).
Right eye was randomly selected in 34 patients and left
eye in 33 patients.
Mean duration of RVO symptoms was 5.6 months
(range: 1–10 months) in CRVO group and 4.8 months
(range: 1–8 months) in BRVO group. We defined ische-
mic type as area of retinal capillary non perfusion
greater than 10 disc area in eyes with CRVO and 5 disc
area in BRVO [23]. In the CRVO group, right eye was
affected in 19 patients and left eye in 18 patients. Ten
patients had ischemic and 27 had non-ischemic CRVO.
Table 2 Patients characteristics
Variables CRVO BRVO Control
Number 37 46 67
Gender (male:female)† 21:16 24:22 34:33
Age (mean ± SD, years)†† 66 ± 14 63 ± 12 64 ± 14
Hypertension (n, %)† 23 (62.16%) 29 (63.04%) 41 (61.19%)
Diabetes mellitus (n, %)† 6 (16.22%) 7 (15.21%) 10 (14.93%)
Chi-squared test was used for categorical variables (†) and one-way ANOVA for
continuous variables (††).
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and left eye in 26 patients. 31 patients had superotem-
poral BRVO and 15 had inferotemporal BRVO, 14 pa-
tients had ischemic and 32 patients had non-ischaemic
BRVO.
Patients with a history of previous intraocular surgery,
eye trauma, any other retinal or neurological disease
(e.g. multiple sclerosis), intraocular inflammation or
tumor, or significant ocular media opacities including
dense cataract that precluded the optical AL measure-
ments were excluded from the study. Exclusion criteria
were the same for control participants with the addition
of presence or history of RVO.
All patients with RVO underwent systemic examina-
tions, including fasting blood glucose level determin-
ation, systemic blood pressure measurement and
detailed cardiovascular and hematological examination.
Ophthalmic examination included best corrected vis-
ual acuity (BCVA, measured with Snellen chart adjusted
at 5 m, converted to logMAR values for analysis), sub-
jective spherical equivalent refraction (SER), slit lamp
biomicroscopy, gonioscopy, intraocular pressure meas-
urement with applanation tonometry, indirect ophthal-
moscopy following pupil dilation and fundus fluorescein
angiography in RVO patients.
Optical biometry of the eyes was performed by the
LenStar LS 900 device (LS 900® Haag-Streit AG, Koeniz,
Switzerland, software version: V1.3.0) which is based on
the principles of OLCR. The instrument uses a broad-
band superluminescent diode light source (peak wave-
length 820 nm) to provide a series of axial biometric
dimensions along the visual axis [22,24,25]. The meas-
urement wavelength and bandwidth of the instrument
equate to an axial resolution of ~ 10 microns, using the
formulas from Tanna et al. [26] For a single measure-
ment, the instrument performs 16 consecutive scans
with each measurement taking ~3-5 seconds [25]. A
minimum of 5 measurements were obtained for every
parameter in each eye for calculating mean values. All
measurements were performed by the same operator
who was masked to the subject’s eye condition.
The OLCR device measures ocular AL as a distance
from the peak of anterior corneal surface to the central
retinal pigment epithelium peak. Keratometry (flat and
steep keratometry), central corneal thickness (CCT),
anterior chamber depth (ACD- length from corneal
epithelium to anterior lens surface), lens thickness (LT),
and AL are automatically derived ocular biometric mea-
sures from the instrument. Average keratometric power
(Kaverage) was calculated as the mean of the flat and the
steep keratometric readings. SER was defined as the spher-
ical power plus half of the minus cylindrical power
(sphere + ½ cylinder). VCD was defined as AL minus ACD
(including CCT) and LT.Statistical analyses were performed using SPSS soft-
ware program (Statistical Package for Social Sciences,
SPSS version 22.0; SPSS Inc., Chicago, IL, USA). P value
of <0.05 was considered statistically significant. Differ-
ences between demographic data of RVO patients and
control group were assessed by Chi-square test for cat-
egorical variables (gender, presence of hypertension and
diabetes mellitus) and one-way univariate analysis of
variance (ANOVA) for continuous variables (age). The
distributions of Kaverage, SER, CCT, ACD, LT, AL, VCD
were confirmed as normally distributed by Kolmogorov-
Smirnov tests and therefore Kaverage, SER, CCT, ACD,
LT, AL, VCD of the eyes with RVO (BRVO or CRVO)
were compared with those of the unaffected fellow eyes
using paired t-test. Kaverage, SER, CCT, ACD, LT, AL,
VCD of the affected and unaffected fellow eyes of pa-
tients with RVO (BRVO or CRVO) were compared with
those of the control eyes using independent t-test.
Results
The characteristics of the patients are summarized in
Table 2. No significant differences were observed between
the groups in terms of age, sex and disease factors, includ-
ing diabetes mellitus and hypertension (p > 0.05).
In the CRVO group, mean BCVA was +0.70 ± 0.63
logMAR in the affected eyes and +0.11 ± 0.36 logMAR
in the unaffected fellow eyes. In the BRVO group, mean
BCVAs of affected and fellow eyes were +0.41 ± 0.40 log-
MAR and +0.06 ± 0.14 logMAR, respectively. BCVA of
control eyes was +0.11 ± 0.22 logMAR.
Tables 3 and 4 show the average group ocular biom-
etry measurements. Comparisons were performed for
SER, Kaverage, CCT, ACD, LT, AL and VCD among con-
trol eyes and affected, unaffected fellow eyes in both
RVO groups, respectively. Mean SER, Kaverage, CCT,
ACD and LT of affected eyes (both CRVO and BRVO
groups), unaffected fellow eyes and control eyes were
not statistically different between groups. Mean AL and
VCD of affected eyes in the CRVO group were signifi-
cantly shorter than those of the control eyes (p = 0.001,
p < 0.05), mean difference was 0.56 ± 0.15 mm in AL and
0.45 ± 0.19 mm in VCD. The mean AL and VCD of af-
fected eyes in CRVO patients were significantly shorter
Table 3 Ocular biometric measurements (mean ± standard deviation) of the affected and unaffected fellow eyes in
CRVO and control eyes
Control eyes CRVO p value
Affected eyes Fellow eyes Affected vs control† Fellow vs control† Affected vs fellow††
SER (D) 0.51 ± 2.22 0.58 ± 2.12 0.53 ± 2.53 0.198 0.971 0.558
Kaverage(D) 43.24 ± 1.46 43.63 ± 1.43 43.65 ± 1.41 0.892 0.190 0.686
CCT (μm) 556.43 ± 43.20 553.76 ± 28.47 552.31 ± 30.30 0.706 0.630 0.684
ACD (mm) 3.11 ± 0.30 3.06 ± 0.43 3.06 ± 0.38 0.549 0.493 0.955
LT (mm) 4.29 ± 0.37 4.33 ± 0.39 4.46 ± 0.41 0.600 0.081 0.068
AL (mm) 23.45 ± 0.69 22.89 ± 0.89 23.28 ± 0.88 0.001* 0.301 0.000*
VCD (mm) 16.03 ± 0.65 15.59 ± 1.06 15.74 ± 0.85 0.022* 0.074 0.013*
P-values of paired (††) and independent (†) t test. Asterisk (*) indicates a difference that is considered statistically significant (p < 0.05).
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0.013)
There was no statistically significant difference be-
tween the affected and unaffected fellow BRVO eyes.
Mean AL and VCD of the affected and unaffected fellow
eyes in the BRVO group were significantly shorter than
those of the control eyes (p < 0.001). AL of the affected
eyes was shorter with a mean difference of 0.57 ±
0.15 mm and VCD was shorter with a mean difference
of 0.61 ± 0.15 mm comparing with the control eyes.
Mean AL of the unaffected fellow eyes was shorter than
the control eyes with 0.53 ± 0.16 mm and VCD was
shorter with a mean difference of 0.35 ± 0.16 mm.
Discussion
In this study we investigated biometry of eyes with ret-
inal vein occlusion using optical low coherence reflect-
ometry. We found shorter axial and vitreous chamber
depth in both CRVO and BRVO eyes compared to age
and gender matched control eyes.
Demographic data and proportion of well-known risk
factors (i.e. hypertension and diabetes mellitus) in our
RVO patients were consistent with previous reports in
the literature [3-6].
The role of AL in CRVO and BRVO patients is still
controversial (Table 1) [9-21]. Some studies did not findTable 4 Ocular biometric measurements (mean ± standard de
BRVO and control eyes
Control eyes BRVO
Affected eyes Fellow eyes
SER (D) 0.51 ± 2.22 0.98 ± 1.79 1.26 ± 1.75
Kaverage (D) 43.24 ± 1.46 43.58 ± 1.29 43.69 ± 1.15
CCT (μm) 556.43 ± 43.20 551.87 ± 43.20 557.09 ± 39.94
ACD (mm) 3.11 ± 0.30 3.18 ± 0.44 3.12 ± 0.43
LT (mm) 4.29 ± 0.37 4.38 ± 0.44 4.39 ± 0.42
AL (mm) 23.45 ± 0.69 22.88 ± 0.93 22.91 ± 0.95
VCD (mm) 16.03 ± 0.65 15.43 ± 0.99 15.68 ± 0.89
P-values of paired (††) and independet (†) t test. Asterisk (*) indicates a difference thdifferences in AL in eyes with CRVO [12,13,19,20] or
BRVO [11-14] compared with unaffected fellow or con-
trol eyes. In contrast to these studies, others found sig-
nificantly shorter AL in the affected eyes of patients with
CRVO [9,14,15,17,18] or with BRVO [9,10,15,17] com-
pared with control eyes, similar to the present study.
In most previous studies [9-19,21], ocular AL was
measured by A-scan ultrasonography, which measures
echo time to determine intraocular distances. The OLCR
biometer has some advantages over conventional ultra-
sound. Clinical resolution of A-scan US in AL measure-
ment was reported to be lower than OLCR. Using a
typical 10-MHz transducer, it has a longitudinal reso-
lution of 200 microns and a clinical accuracy of 100 to
120 microns compared to 12 microns for AL measure-
ments by OLCR [22,27,28].
With OLCR biometry more accurate AL measurements
are obtained compared to applanation ultrasound, which
inevitably leads to corneal indentation from the ultra-
sound probe, and artificially shortened AL readings [27].
According to previous studies [29,30], AL measure-
ments using US A-scan and optical biometers in eyes with
cystoid macular edema differ significantly. Ueda et al. [29]
evaluated the relationship between the difference in AL
measurements with US A-scan and partial coherence laser
interferometry and macular retinal thickness in patientsviation) of the affected and unaffected fellow eyes in
p value
Affected vs control† Fellow vs control† Affected vs fellow††
0.253 0.068 0.232
0.219 0.105 0.349
0.565 0.936 0.121
0.421 0.942 0.447
0.201 0.177 0.949
0.000* 0.001* 0.375
0.000* 0.000* 0.709
at is considered statistically significant (p < 0.05).
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tween AL intermethod difference and retinal thickness, if
retinal thickness was more than 200 microns. This is likely
a result of the fundamentally different methodology of the
two device in measuring eyes with a pathologically
thickened retina [29,30]. Conventional US A-scan mea-
sures the distance between the anterior corneal apex
and the internal limiting membrane of the retina,
whereas the optical AL is measured from the anterior
corneal surface to the central peak of retinal pigment
epithelium instead of the vitreoretinal interface, mean-
ing that any change in retinal thickness (such macular
edema) will not affect the overall AL measurement.
In previous studies [9-19,21], shorter ocular ALs in
RVO eyes were measured by A scan US, and these re-
sults may due to macular edema complications of RVO
[20]. Therefore in our study we choose the OLCR device
in order to avoid measurement altering effects of macu-
lar edema.
Moghimi et al. [20] studied 29 patients with unilateral
CRVO by partial coherence laser interferometry and did
not find any significant difference in AL comparing af-
fected eyes with unaffected fellow eyes. They described a
statistically significant shorter posterior segment length
(which was calculated as AL minus ACD) in affected
eyes, although they did not have control eyes of un-
affected patients. The role of shorter posterior part of
the eye in CRVO was first emphasized by Moghimi
et al., but they did not study the lens thickness and the
vitreous chamber depth, therefore the exact structural
correlate could not be determined.
In our study besides AL, other biometrical parameters
(CCT, ACD, LT) of eyes in patients with RVO and age-
and gender-matched control group were measured,
allowing us to determine that CCT, ACD and LT of the
affected eyes, unaffected fellow eyes, and control eyes
did not differ statistically in patients with either CRVO
or BRVO. We observed significantly shorter AL in the
affected eyes of patients with CRVO and BRVO com-
pared with control eyes. Mean CCT, ACD and LT of the
affected eyes, unaffected fellow eyes and control eyes did
not differ statistically either in patients with CRVO or
BRVO. Therefore the finding that AL was significantly
shortened in CRVO and BRVO affected eyes compared
with controls can be attributed to a shorter VCD.
Using ultrasound, multiple authors have reported
significantly shorter AL in the affected eyes of patients
with CRVO [9,14,17,21] and BRVO [15-17] compared
with unaffected fellow eyes. It was argued that significant
differences between AL in RVO eyes and unaffected fellow
eyes could be due to the effect of macular edema in AL
measurements [9,20].
In our study, both eyes in patients BRVO were signifi-
cantly shorter than control eyes, however we did notfind any significant difference in AL between affected
and unaffected fellow eyes in patients with BRVO. Evi-
dence on symmetry between two eyes of the same per-
son has been reported previously, with Rajan et al. [31]
reporting that 76% of patients had less than a 0.3 mm
interocular difference in AL, and Jabbour [32] reporting
a mean difference of 0.0028 ± 0.24 mm in AL between
eyes. In our study the lack of significant difference be-
tween the AL of the affected and unaffected fellow eyes
in BRVO patients is consistent with reports of normal
interocular symmetry. In the CRVO group however, the
mean AL of affected eyes was significantly shorter than
those of the unaffected fellow eyes. These results sup-
port evidence that CRVO develops less frequently in
both eyes than BRVO, with estimates that 1.4% of CRVO
cases developed CRVO in the fellow eye over a 3-year
period [30] compared with BRVO which developed in
the fellow eye in 4.5-9% of BRVO cases [33,34].
According to previous histopathological studies thrombus
formation was observed at or near the lamina cribrosa in
eyes with CRVO [35] and at the arteriovenous junction in
BRVO [36]. The sieve-like structure of the lamina cribrosa
which is formed from interweaving fascicles of collagen
bundles with no elasticity restricts the expansion of the
vessels passing through it [9]. The thickness of the lam-
ina cribrosa and peripapillary sclera adjacent to the
optic nerve scleral canal increase significantly with de-
creasing AL [37]. Furthermore, shorter AL is associated
with decreased disc area in normal subjects [38].
Cekic et al. [14] suggested that eyes with shorter AL
may be predisposed to greater crowding of the central
retinal vein and artery at the lamina cribrosa, and are
therefore more likely to develop CRVO. It is postulated
that shorter eyes have a smaller disc and a narrower
scleral canal through which the retinal vessels are more
tightly confined. This may reduce the blood flow in the
vein and may lead to increased blood flow turbulence
that could cause endothelial damage and thrombus
formation at the lamina cribrosa and at further arterio-
venous crossings [13,21]. This theory of anatomical re-
striction in the posterior pole of shorter eyes is
supported by our findings of shorted AL and VCD in
eyes with BRVO and CRVO when compared with con-
trol eyes.
There are several limitations of our study. Firstly, we
evaluated only the presence of hypertension and diabetes
mellitus in our subjects. Other systemic risk factors such
as hyperlipidemia, cardiovascular diseases, blood hyper-
viscosity and diseases with hypercoagulation were not
studied. Secondly, the limitation of optical biometry is
its inability to measure through dense cataracts and
other media opacities that obscure the macula, therefore
patients with significant ocular media opacities were not
enrolled.
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To our knowledge this is the first study using optical
low coherence reflectometry that found significant asso-
ciation between shorter axial length, vitreous chamber
depth and retinal vein occlusion. Other anterior segment
parameters (Kaverage, CCT, ACD, LT) did not differ sig-
nificantly in affected, unaffected fellow and control eyes.
Difference in axial length between affected and control
eyes is a result of shorter vitreous chamber depth along
the visual axis in patients with RVO. Our results suggest
that besides other risks, shorter axial and vitreous cham-
ber depth might be an additional potential anatomical
predisposing factor for the development of retinal vein
occlusion.
In contrast to previous studies using US devices mea-
surements performed with OLCR were not affected by
the presence of macular edema.
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